Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Inclusion Criteria

• •Signature of the informed consent and consent to the use of personal data
• •Prostate Specific Antigen (PSA) \< 20 ng/mL
• •Unilateral organ-confined disease on MRI (performed according to ESUR recommendations and reported according to PiRads V.2) or PET-PSMA (performed according to the recommendations of the EANM and reported according to "EANM standardized reporting guidelines v1.0 for PSMA-PET")
• •Histological diagnosis of acinar-type prostate cancer unilateral on target biopsy and/or standard biopsy with ISUP \< 3 and ipsilateral on imaging investigations
• •Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1
• •Life expectancy ≥ 5 years
• •Availability of the patient's pre-operative clinical data
• •Patients must be available to carry out the follow-up visits defined by the protocol
• •Absence of retroperitoneal, lymph nodal, bone or visceral metastatic lesions
• •Patients eligible for robot-assisted radical prostatectomy